Sana Biotechnology’s hypoimmune platform enables it to make a series of genetic modifications to cells, rendering the cells ...

The following is a summary of “Identification of a pancreatic stellate cell gene signature and lncRNA interactions associated ...

Implantable Continuous Glucose Monitoring System Market Indicate 30. 2 Billion USD Revenue By 2032 At A 15. 61% CAGR The rising prevalence of diabetes and the growing adoption of continuous glucose ...

Risk for pancreatitis was not elevated among users of tirzepatide relative to placebo, despite the presence of elevated pancreatic enzymes.

Sana Biotechnology said a type 1 diabetes (T1D) patient received an allogeneic primary islet cell transplantation without ...

It can generate billions in revenue from both acute and possibly chronic pain. If approved, it would give Vertex ...

Among those who have had gestational diabetes, about 35% will develop type 2 diabetes within a decade. A new study led by Dr.

Recent advances in immunotherapy have revealed a promising frontier in Type 1 diabetes treatment: outsmarting rather than ...

Completed enrollment in Phase 2 BESTOW trial assessing tegoprubart in kidney transplantation four months ahead of schedule; on track to report topline results in fourth quarter of 2025 Presented updat ...

Completed enrollment in Phase 2 BESTOW trial assessing tegoprubart in kidney transplantation four months ahead of schedule; on track to report topline results in fourth quarter of 2025 Presented updat ...

Researchers from Tokyo Metropolitan University have uncovered a significant link between age-related diabetes and the loss of ...